Prospective Study of Diagnostic Accuracy of Spectral CT for the Detection of Bone Marrow Edema

November 21, 2023 updated by: University Hospital Augsburg

Prospective Observational Study of Diagnostic Accuracy of Dual-Energy-/Multi-Energy-CT for the Detection of Bone Marrow Edema

Dual-Energy/Multi-Energy/Spectral-CT can visualize bone marrow edema associated with fractures, however, current scientific evidence is mostly derived from to retrospective analyses. Our prospective study systematically analyzes the diagnostic accuracy of the visualization of bone marrow edema by including patients who are scheduled for a CT scan to exclude or further characterize a fracture. After giving informed consent, the CT scan will be performed using a dose-neutral Dual-Energy-/Multi-Energy-/Spectral-CT acquisition technique. If the patient undergoes MRI of the same region within 7 days, this scan will be used as a gold-standard for bone marrow edema. This will allow the quantification of diagnostic accuracy.

Study Overview

Study Type

Observational

Enrollment (Estimated)

800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients who are at least 18 years of age who are referred by the emergency department for a CT scan with the suspicion of a fracture.

Description

Inclusion Criteria:

  • clinical suspicion for a fracture AND
  • indication for CT confirmed by board-certified radiologist ('justified indication' according to German/European radiation protection law) AND
  • patient (is able to give informed consent and) has given informed consent.

Exclusion Criteria:

  • cardiorespiratory instability (as judged by the referring physician)
  • age < 18 years
  • known or suspected pregnancy
  • known bone metastases of a malignant disease
  • known rheumatic disease
  • metal implants in the region to be scanned
  • surgical intervention over the last 12 months in the region to be scanned
  • contraindications for MRI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Prospective Cohort
400 patients who are scheduled to undergo a clinically requested CT scan of parts of the skeleton using a Dual-Energy/Multi-Energy/Spectral acquisition mode to exclude or further define bone fractures.
CT acquisition using a Dual-Energy / Multi-Energy / Spectral acquisition mode
Other Names:
  • Spectral Imaging
Retrospective Cohort
400 patients who had undergone a clinically requested CT scan of the skeleton in standard acquisition mode in the past to exclude or further define bone fractures.
CT acquisition using a standard single energy / non-spectral acquisition mode

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic Accuracy of Dual-Energy/Multi-Energy/Spectral CT to detect bone marrow edema in comparison with MRI as the goldstandard.
Time Frame: MRI of the same region can be used for comparison if performed within 7 days
sensitivity, specificity and positive and negative likelihood ratios will be assessed
MRI of the same region can be used for comparison if performed within 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Schwarz, MD, University Hospital Augsburg

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2021

Primary Completion (Estimated)

May 31, 2025

Study Completion (Estimated)

May 31, 2025

Study Registration Dates

First Submitted

July 5, 2021

First Submitted That Met QC Criteria

July 5, 2021

First Posted (Actual)

July 15, 2021

Study Record Updates

Last Update Posted (Estimated)

November 22, 2023

Last Update Submitted That Met QC Criteria

November 21, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 21-0318

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We plan to share individual participant data upon request (pending final approval by the data protection officer of the university hospital).

IPD Sharing Time Frame

Requests for sharing individual participant data will be considered at the time of publication of the first manuscript containing result data.

IPD Sharing Access Criteria

We plan to share data on request at this point in time.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fractures, Bone

Clinical Trials on Computed Tomography of the skeleton using a Dual-Energy-/Multi-Energy-/Spectral acquisition mode

Subscribe